#53 – Tessa Alexanian and Janvi Ahuja on Synthetic Biology and GCBRs
Hear This Idea
00:00
Is Biotechnology Just Like Moving Really Fast?
It's very hard to regulate at the pace of technology, and biotechnology is only speeding up yet. We're constantly sort of developing new capabilities, which are labelled as transfer risks. As we get better at editing these things there, theyre also develope these dul used capabilities with technologies that we're never intentioned to serve a malicious purpose. Theres like, less bottle necks or something, right, where you can just below. Ka, as long as we've got like, you know, ten labs or something, covered, will be fine.
Transcript
Play full episode
